Logout
Lundbeck sites
Contact Us
About Cipralex
Key publications
Q & A
Prescribing information
You are here:
Front page
»
About Cipralex
»
Indications
»
Efficacy in social anxiety disorder (SAD)
PRINT
TIP A COLLEAGUE
About Cipralex
Indications
Efficacy in major depressive disorder (MDD)
Efficacy in generalised anxiety disorder (GAD)
Efficacy in social anxiety disorder (SAD)
Efficacy in panic disorder (PD)
Efficacy in obsessive compulsive disorder (OCD)
Tolerability
Adverse events
Discontinuation symptoms
Overdose
Alcohol use
Special populations
Other tolerability aspects
Fast onset of action
Cipralex vs. venlafaxine XR
Cipralex vs. citalopram
How does it work?
Serotonin Dual-Action
Visualisations
Treatment with Cipralex
Efficacy in social anxiety disorder (SAD)
Cipralex vs. paroxetine
After 24 weeks’ treatment, escitalopram (20 mg/day) showed superior efficacy to paroxetine (20 mg/day) in SAD.
Cipralex vs. placebo
In SAD, Cipralex showed superior efficacy over placebo on the Liebowitz Social Anxiety Scale (LSAS).
Clinical relevance of Cipralex compared with placebo was indicated by the improvement of work and social-life items of the Sheehan disability scale.
Key publications
Superior efficacy within anxiety
About Cipralex
Key publications
Q & A
Prescribing information
www.irecover.com
www.mypdinfo.com
www.ebixa.com
www.azilect.com
www.serdolect.com
www.depnet.com
Disclaimer